id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2005-E-0361-0006,FDA,FDA-2005-E-0361,Certificate Extending Patent Term from U.S. Patent and Trademark Office to Buchanan Ingersol PC,Rule,Certificate Extending Patent Term,2007-04-23T04:00:00Z,2007,4,,,2025-12-03T21:46:45Z,,0,0,090000648044aa3f
FDA-2005-E-0361-0005,FDA,FDA-2005-E-0361,Notice of Final Determination and Requirement for Election from U.S. Patent and Trademark Office to Buchanan Ingersoll PC,Other,Letter(s),2007-02-06T05:00:00Z,2007,2,,,2025-12-03T21:45:50Z,,0,0,090000648044aa3d
FDA-2005-E-0361-0004,FDA,FDA-2005-E-0361,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2006-09-08T04:00:00Z,2006,9,,,2025-12-03T21:43:43Z,,0,0,090000648044aa3b
FDA-2005-E-0361-0003,FDA,FDA-2005-E-0361,Determination of Regulatory Review Period for Purposes of Patent Extension; OMACOR,Notice,General Notice,2006-02-02T05:00:00Z,2006,2,2006-02-02T05:00:00Z,,2025-12-03T21:42:03Z,E6-1365,0,0,090000648044aa36
FDA-2005-E-0361-0002,FDA,FDA-2005-E-0361,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2006-01-11T05:00:00Z,2006,1,,,2025-12-03T21:38:25Z,,0,0,090000648044aa33
FDA-2005-E-0361-0001,FDA,FDA-2005-E-0361,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2005-06-22T04:00:00Z,2005,6,,,2025-12-03T21:35:36Z,,0,0,090000648044aa01